Chimera Bioengineering's Unattributed VC Round

Chimera Bioengineering raised a round of funding on September 13, 2017. Investors include Kairos Ventures.

Chimera Bioengineering is a biotherapeutics company building RNA based gene regulatory systems for chimeric antigen receptor CAR-T cell therapeutics with greater efficacy against solid tumors.…

Articles about Chimera Bioengineering's Unattributed VC Round: